Artemis Therapeutics Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating income was USD 57,000 compared to USD 70,000 a year ago. Net loss was USD 6,000 compared to USD 69,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, operating income was USD 76,000 compared to USD 90,000 a year ago. Net loss was USD 27,000 compared to USD 90,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.